Vivos Therapeutics (VVOS) PT Raised to $2.90 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts VVOS Hot Sheet
Price: $0.34 +9.68%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ascendiant Capital analyst Lucas Ward raised the price target on Vivos Therapeutics (NASDAQ: VVOS) to $2.90 (from $2.80) while maintaining a Buy rating.
You May Also Be Interested In
- Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
